The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice.
Identifieur interne : 000E12 ( PubMed/Corpus ); précédent : 000E11; suivant : 000E13The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice.
Auteurs : Florian Reinhart ; Nabil El Massri ; Napoleon Torres ; Claude Chabrol ; Jenny Molet ; Daniel M. Johnstone ; Jonathan Stone ; Alim-Louis Benabid ; John Mitrofanis ; Cécile MoroSource :
- Neuroscience research [ 1872-8111 ] ; 2017.
Abstract
We have shown previously that when applied separately, 670nm and 810nm near infrared light (NIr) reduces behavioural deficits and offers neuroprotection in a MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease. Here, we explored the beneficial outcomes when these NIr wavelengths were applied both together, either concurrently (at the same time) or sequentially (one after the other). Mice received MPTP injections (total of 50mg/kg) and had extracranial application of 670nm and/or 810nm NIr. Behavioural activity was tested with an open-field test and brains were processed for tyrosine hydroxylase immunohistochemistry and stereology. Our results showed that when 670nm and 810nm NIr were applied both together and sequentially, there was a greater overall beneficial outcome - increased locomotor activity and number of tyrosine hydroxylase immunoreactive cells in the substantia nigra pars compacta - than when they were applied either separately, or in particular, both together and concurrently. In summary, our findings have important implications for future use of NIr therapy in humans, that there are some combinations of wavelengths that provide more beneficial outcome than others.
DOI: 10.1016/j.neures.2016.11.006
PubMed: 27871905
Links to Exploration step
pubmed:27871905Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice.</title>
<author><name sortKey="Reinhart, Florian" sort="Reinhart, Florian" uniqKey="Reinhart F" first="Florian" last="Reinhart">Florian Reinhart</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Massri, Nabil El" sort="Massri, Nabil El" uniqKey="Massri N" first="Nabil El" last="Massri">Nabil El Massri</name>
<affiliation><nlm:affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Torres, Napoleon" sort="Torres, Napoleon" uniqKey="Torres N" first="Napoleon" last="Torres">Napoleon Torres</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chabrol, Claude" sort="Chabrol, Claude" uniqKey="Chabrol C" first="Claude" last="Chabrol">Claude Chabrol</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Molet, Jenny" sort="Molet, Jenny" uniqKey="Molet J" first="Jenny" last="Molet">Jenny Molet</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Johnstone, Daniel M" sort="Johnstone, Daniel M" uniqKey="Johnstone D" first="Daniel M" last="Johnstone">Daniel M. Johnstone</name>
<affiliation><nlm:affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stone, Jonathan" sort="Stone, Jonathan" uniqKey="Stone J" first="Jonathan" last="Stone">Jonathan Stone</name>
<affiliation><nlm:affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mitrofanis, John" sort="Mitrofanis, John" uniqKey="Mitrofanis J" first="John" last="Mitrofanis">John Mitrofanis</name>
<affiliation><nlm:affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia. Electronic address: john.mitrofanis@sydney.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Moro, Cecile" sort="Moro, Cecile" uniqKey="Moro C" first="Cécile" last="Moro">Cécile Moro</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:27871905</idno>
<idno type="pmid">27871905</idno>
<idno type="doi">10.1016/j.neures.2016.11.006</idno>
<idno type="wicri:Area/PubMed/Corpus">000E12</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E12</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice.</title>
<author><name sortKey="Reinhart, Florian" sort="Reinhart, Florian" uniqKey="Reinhart F" first="Florian" last="Reinhart">Florian Reinhart</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Massri, Nabil El" sort="Massri, Nabil El" uniqKey="Massri N" first="Nabil El" last="Massri">Nabil El Massri</name>
<affiliation><nlm:affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Torres, Napoleon" sort="Torres, Napoleon" uniqKey="Torres N" first="Napoleon" last="Torres">Napoleon Torres</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chabrol, Claude" sort="Chabrol, Claude" uniqKey="Chabrol C" first="Claude" last="Chabrol">Claude Chabrol</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Molet, Jenny" sort="Molet, Jenny" uniqKey="Molet J" first="Jenny" last="Molet">Jenny Molet</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Johnstone, Daniel M" sort="Johnstone, Daniel M" uniqKey="Johnstone D" first="Daniel M" last="Johnstone">Daniel M. Johnstone</name>
<affiliation><nlm:affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stone, Jonathan" sort="Stone, Jonathan" uniqKey="Stone J" first="Jonathan" last="Stone">Jonathan Stone</name>
<affiliation><nlm:affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mitrofanis, John" sort="Mitrofanis, John" uniqKey="Mitrofanis J" first="John" last="Mitrofanis">John Mitrofanis</name>
<affiliation><nlm:affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia. Electronic address: john.mitrofanis@sydney.edu.au.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Moro, Cecile" sort="Moro, Cecile" uniqKey="Moro C" first="Cécile" last="Moro">Cécile Moro</name>
<affiliation><nlm:affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Neuroscience research</title>
<idno type="eISSN">1872-8111</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have shown previously that when applied separately, 670nm and 810nm near infrared light (NIr) reduces behavioural deficits and offers neuroprotection in a MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease. Here, we explored the beneficial outcomes when these NIr wavelengths were applied both together, either concurrently (at the same time) or sequentially (one after the other). Mice received MPTP injections (total of 50mg/kg) and had extracranial application of 670nm and/or 810nm NIr. Behavioural activity was tested with an open-field test and brains were processed for tyrosine hydroxylase immunohistochemistry and stereology. Our results showed that when 670nm and 810nm NIr were applied both together and sequentially, there was a greater overall beneficial outcome - increased locomotor activity and number of tyrosine hydroxylase immunoreactive cells in the substantia nigra pars compacta - than when they were applied either separately, or in particular, both together and concurrently. In summary, our findings have important implications for future use of NIr therapy in humans, that there are some combinations of wavelengths that provide more beneficial outcome than others.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27871905</PMID>
<DateCreated><Year>2016</Year>
<Month>11</Month>
<Day>22</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>04</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8111</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>117</Volume>
<PubDate><Year>2017</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Neuroscience research</Title>
<ISOAbbreviation>Neurosci. Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice.</ArticleTitle>
<Pagination><MedlinePgn>42-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0168-0102(16)30252-8</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neures.2016.11.006</ELocationID>
<Abstract><AbstractText>We have shown previously that when applied separately, 670nm and 810nm near infrared light (NIr) reduces behavioural deficits and offers neuroprotection in a MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease. Here, we explored the beneficial outcomes when these NIr wavelengths were applied both together, either concurrently (at the same time) or sequentially (one after the other). Mice received MPTP injections (total of 50mg/kg) and had extracranial application of 670nm and/or 810nm NIr. Behavioural activity was tested with an open-field test and brains were processed for tyrosine hydroxylase immunohistochemistry and stereology. Our results showed that when 670nm and 810nm NIr were applied both together and sequentially, there was a greater overall beneficial outcome - increased locomotor activity and number of tyrosine hydroxylase immunoreactive cells in the substantia nigra pars compacta - than when they were applied either separately, or in particular, both together and concurrently. In summary, our findings have important implications for future use of NIr therapy in humans, that there are some combinations of wavelengths that provide more beneficial outcome than others.</AbstractText>
<CopyrightInformation>Copyright © 2016 Elsevier Ireland Ltd and Japan Neuroscience Society. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinhart</LastName>
<ForeName>Florian</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Massri</LastName>
<ForeName>Nabil El</ForeName>
<Initials>NE</Initials>
<AffiliationInfo><Affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Torres</LastName>
<ForeName>Napoleon</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chabrol</LastName>
<ForeName>Claude</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Molet</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Johnstone</LastName>
<ForeName>Daniel M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo><Affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stone</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Dept of Physiology F13, University of Sydney, 2006, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Benabid</LastName>
<ForeName>Alim-Louis</ForeName>
<Initials>AL</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mitrofanis</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Dept of Anatomy F13, University of Sydney, 2006, Australia. Electronic address: john.mitrofanis@sydney.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moro</LastName>
<ForeName>Cécile</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>CLINATEC, EJ Safra Centre, CEA, LETI, University of Grenoble Alpes, F38000, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>11</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Ireland</Country>
<MedlineTA>Neurosci Res</MedlineTA>
<NlmUniqueID>8500749</NlmUniqueID>
<ISSNLinking>0168-0102</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Open-field test</Keyword>
<Keyword MajorTopicYN="N">Parkinson’s disease</Keyword>
<Keyword MajorTopicYN="N">Photobiomodulation</Keyword>
<Keyword MajorTopicYN="N">Substantia nigra</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2016</Year>
<Month>10</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>11</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>11</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>11</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>11</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27871905</ArticleId>
<ArticleId IdType="pii">S0168-0102(16)30252-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.neures.2016.11.006</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E12 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000E12 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:27871905 |texte= The behavioural and neuroprotective outcomes when 670nm and 810nm near infrared light are applied together in MPTP-treated mice. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27871905" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |